18.02 USD
↘ 0.57 (3.09%)PRE MARKET (AS OF 04:06 AM EDT)
Greenwich LifeSciences, Inc.
GLSINASDAQ • USD
Market: OPEN
GLSI is currently priced at $18.02. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Aug 26, 2026.
Open?$18.20
High?$18.20
Low?$18.02
Prev. Close?$18.59
Volume?3
Avg. Volume?161.1K
VWAP?$18.20
Rel. Volume?0.00x
Bid / Ask
Bid?$15.52 × 100
Ask?$21.64 × 100
Spread?$6.12
Midpoint?$18.58
Valuation & Ratios
Market Cap?267.6M
Shares Out?14.7M
Float?6.3M
Float %?43.2%
P/E Ratio?N/A
P/B Ratio?85.85
EPS?-$1.48
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9-amino-acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including breast cancers at low (1+), intermediate (2+), and high (3+ or overexpressing) levels.
Employees
13
Market Cap
272.9M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-09-25
Address
3992 BLUEBONNET DR, BUILDING 14
STAFFORD, TX 77477
Phone: 203-434-3290
STAFFORD, TX 77477
Phone: 203-434-3290
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?98
Momentum?50
Short Sent.?10
Piotroski F-Score?0/9Weak
Altman Z-Score?4.91Safe
Confidence?48%Low
Short InterestSqueeze Risk
Short % of Float?25.13%Squeeze Risk
Short Interest?1.6M
Days to Cover?13.3
Free Float6.3M
Avg Daily Volume120.1K
Settlement Date2026-08-14
Financial Health
Current Ratio?1.54Adequate
Quick Ratio?1.54Adequate
Cash Ratio?1.54Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?85.85HIGH▾
Peers100
S&P3
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-11.8CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-695.6%WEAK▾
S&P3
ROA?-244.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-12488140
Enterprise Value?$258.7M
Fundamentals ratios updated end of day